SEROQUEL XR (EXTENDED RELEASE QUETIAPINE FUMARATE) LITIGATION

CASE NO. 19-CV-08296 (S.D.N.Y.)

LGN represents end payor plaintiffs who allege that a drug company entered into unlawful agreements with two other drug companies not to compete in the market for Seroquel XR and corresponding generic versions.  This action is pending in the United States District Court of the Southern District of New York before the Honorable Colleen McMahon.